0
Skip to Content
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
Search
English
DONATE
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
Search
English
DONATE
For Patients
For Researchers
For Clinicians
Take Action
About Us
Search
English
Back
DONATE
  • Medical Education Webinars,
  • Patient Videos & Webinars,
• 8/7/24

2021 RUNX1 Week Keynote Speaker: Dr. David Fajgenbaum

Dr. David Fajgenbaum, co-founder and CEO of the Castleman Disease Collaborative Network, discusses his personal battle with this rare disease that almost killed him several times, and his tireless research that led to the discovery of a life-saving treatment for himself and many other Castleman patients.

Previous

Hereditary Hematologic Malignancy Assessment: Making it Mainstream

Next

Inherited Thrombocytopenia (ITP): What Is It, Whom To Test and How To Test?

You Might Also Like

Related Embedded Video Item Thumbnail Introduction to the Sirolimus Pilot Study (8.9.24)
Related Embedded Video Item Thumbnail "Mechanisms underlying aging associated increased heterogeneity and selection for clonal hematopoiesis mutations in hematopoietic stem cell pools."
Related Embedded Video Item Thumbnail Module 3: The Potential Promise and Current Challenges of Gene Editing
Related Embedded Video Item Thumbnail Transcription Factor Associations Fine-Tune Expression of the RUNX1 Gene Network to Confer Regulatory Logic to Hematopoietic Gene Expression Programs
Related Embedded Video Item Thumbnail Introduction To The Stem Cell Harvesting & Banking Clinical Trial

Sign Up For Our Email List!

Enter your information below to receive the
latest RUNX1 news and updates!

Stay In Touch

Email RRP

Newsletter

Policies

Privacy Policy

Cookie Policy

Accessibility Statement

Site Resources

News & Updates

Calendar of Events

RRP Blog

DONATE
SHOP